Oxford BioDynamics Plc (LON:OBD – Get Rating)’s stock price shot up 2.9% on Friday . The company traded as high as GBX 17 ($0.21) and last traded at GBX 16.85 ($0.21). 24,196 shares changed hands during trading, a decline of 90% from the average session volume of 239,287 shares. The stock had previously closed at GBX 16.38 ($0.21).
Analyst Ratings Changes
Separately, Shore Capital reiterated a “house stock” rating on shares of Oxford BioDynamics in a report on Tuesday, January 24th.
Oxford BioDynamics Trading Up 2.9 %
The company has a quick ratio of 2.80, a current ratio of 0.95 and a debt-to-equity ratio of 237.09. The stock’s fifty day moving average price is GBX 15.85 and its two-hundred day moving average price is GBX 17.36. The company has a market capitalization of £24.72 million, a PE ratio of -240.71 and a beta of 1.14.
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment.
Further Reading
- MarketBeat Week in Review – 5/8 – 5/12
- An Updraft Is Brewing For DraftKings
- PepsiCo Hits “Sweet Spot” For APAC Growth, Macros Agree
- High-Risk Mullen Automotive Continues To Build Momentum
- 3 Recession-Proof Stocks With Nice Dividends
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.